Human fibrinogen (Shandong Taibang Biological Products)

人纤维蛋白原（山东泰邦生物）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman fibrinogen (Shandong Taibang Biological Products)
Drug Alias NameN/A
ClassificationBiologics > Blood components
Mechanisms of ActionFibrinogen replacements
TargetsFibrinogen
Therapy Area/IndicationsBlood Loss, SurgicalHemorrhageAfibrinogenemia
Global Approved IndicationsAfibrinogenemia
Approved Indications in ChinaAfibrinogenemia
Original Approved Country/TerritoryMainland China
Original Approved Date2017/09/20
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShandong Taibang Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShandong Taibang Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsBlood Loss, SurgicalHemorrhageAfibrinogenemia
Inactive IndicationsN/A

Other Information

ATC CodeB02BB01
Related LinksN/A